Personensuche

Personensuche

Bitte geben Sie den Namen der gesuchten Person ein.

Es wurde 1 Person gefunden.

Ph.D Tibor Szarvas

Funktionen

  • Nebenberuflich Lehrende/r, Klinik für Urologie

Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.

    Artikel in Zeitschriften

  • Szabó, Anett; Váncsa, Szilárd; Hegyi, Péter; Kói, Tamás; Ács, Júlia; Hermánné, Réka Juhász; Ács, Nándor; Szarvas, Tibor; Nyirády, Péter; Kopa, Zsolt
    Assessing the efficacy of varicocelectomy, antioxidants, FSH treatment, and lifestyle modifications on sperm DNA fragmentation : a systematic review and meta-analysis
    In: Scientific Reports, Jg. 15, 2025, Nr. 1, 10118
    DOI (Open Access)
  • Altenni, Mohammed; Fehérvári, Péter; Hoferica, Jakub; Hegyi, Péter; Ács, Nándor; Fazekas, Tamás; Vargha, Judit; Grünwald, Viktor; Darr, Christopher; Riesz, Péter; Nyirády, Péter; Szarvas, Tibor
    Clinical and Molecular Predictors of Response and Survival in Patients with Urothelial Carcinoma Treated with Enfortumab Vedotin : A Systematic Review and Meta-analysis
    In: European Urology Open Science, Jg. 82, 2025, S. 100 – 110
    DOI (Open Access)
  • Váradi, M.; Horváth, O.; Soós, E.; Csizmarik, A.; Németh, B.; Győrffy, B.; Kenessey, I.; Reis, H.; Koll, F.; Oláh, C.; Hadaschik, Boris; Krafft, Ulrich; Grünwald, Viktor; Mairinger, F.; Wessolly, M.; Hoffmann, M.J.; Grunewald, C.M.; Niegisch, G.; Cotarelo, C.L.; Maráz, A.; Kuthi, L.; Szász, A.M.; Herold, Z.; Posta, M.; Bátai, B.; Nyirády, P.; Szarvas, Tibor
    Combining molecular patterns and clinical data for better immune checkpoint inhibitor prediction in metastatic urothelial carcinoma
    In: Cancer Immunology, Immunotherapy, Jg. 74, 2025, Nr. 12, 370
    DOI (Open Access)
  • Olah, Csilla; Mairinger, Fabian; Wessolly, Michael; Joniau, Steven; Spahn, Martin; Kruithof-de Julio, Marianna; Hadaschik, Boris; Soós, Aron; Nyirády, Péter; Győrffy, Balázs; Reis, Henning; Szarvas, Tibor
    Enhancing risk stratification models in localized prostate cancer by novel validated tissue biomarkers
    In: Prostate Cancer and Prostatic Diseases, Jg. 28, 2025, Nr. 3, S. 773 – 781
    DOI (Open Access)
  • Olah, Csilla; Shmorhun, Oleksandr; Klamminger, Gilbert Georg; Rawitzer, Josefine; Sichward, Lara; Hadaschik, Boris; Al-Nader, Mulham; Krafft, Ulrich; Niedworok, Christian; Váradi, Melinda; Nyirady, Peter; Kiss, Andras; Szekely, Eszter; Reis, Henning; Szarvas, Tibor
    Immunohistochemistry-based molecular subtypes of urothelial carcinoma derive different survival benefit from platinum chemotherapy
    In: The Journal of Pathology: Clinical Research, Jg. 11, 2025, Nr. 1, e70017
    DOI (Open Access)
  • Al-Nader, Mulham; Krafft, Ulrich; Darr, Christopher; Heß, Jochen; Kesch, Claudia; Püllen, Lukas; Szarvas, Tibor; Reis, Henning; Tschirdewahn, Stephan; Hadaschik, Boris A.; Mahmoud, Osama
    Impact of Extended Versus Limited Lymph Node Dissection on Surgical Outcome, Recurrence Patterns and Survival After Radical Cystectomy
    In: Clinical Genitourinary Cancer, Jg. 23, 2025, Nr. 3, 102337
    DOI
  • Juhász, Dániel; Csizmarik, Anita; Váradi, Melinda; Bacsó, Dániel; Kubik, András; Szűcs, Miklós; Székely, Eszter; Al-Nader, Mulham; Mahmoud, Osama; Krafft, Ulrich; Hadaschik, Boris; Nyirády, Péter; Szarvas, Tibor
    Lymphovascular Invasion is Predictive for Adjuvant Platinum Therapy Benefit in Urothelial Bladder Cancer
    In: Clinical Genitourinary Cancer, Jg. 23, 2025, Nr. 6, 102421
    DOI (Open Access)
  • Bartha, Áron; Weltz, Boglárka; Betancourt, Lazaro Hiram; Gil, Jeovanis; Pinto de Almeida, Natália; Bianchini, Giampaolo; Szeitz, Beáta; Szadai, Leticia; Pla, Indira; Kemény, Lajos; Jánosi, Ágnes Judit; Hong, Runyu; Rajeh, Ahmad; Nogueira, Fábio; Doma, Viktória; Woldmar, Nicole; Guedes, Jéssica; Újfaludi, Zsuzsanna; Kim, Yonghyo; Szarvas, Tibor; Pahi, Zoltan; Pankotai, Tibor; Szasz, A. Marcell; Sanchez, Aniel; Baldetorp, Bo; Tímár, József; Németh, István Balázs; Kárpáti, Sarolta; Appelqvist, Roger; Domont, Gilberto Barbosa; Pawlowski, Krzysztof; Wieslander, Elisabet; Malm, Johan; Fenyo, David; Horvatovich, Peter; Marko-Varga, György; Győrffy, Balázs
    Melanoma Proteomics Unveiled : Harmonizing Diverse Data Sets for Biomarker Discovery and Clinical Insights via MEL-PLOT
    In: Journal of Proteome Research, Jg. 24, 2025, Nr. 6, S. 3117 – 3128
    DOI (Open Access)
  • Mahmoud, Osama; Püllen, Lukas; Umutlu, Lale; Szarvas, Tibor; Fendler, Wolfgang; Ting, Saskia; Reis, Henning; Bayer, Henning; Herrmann, Ken; Hadaschik, Boris; Al-Nader, Mulham; Berliner, Christoph
    Multitracer comparison of gold standard PSMA-PET/CT with 68Ga-FAPI and 18F-FDG in high-risk prostate cancer : a proof-of-concept study
    In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 52, 2025, Nr. 13, S. 4860 – 4869
    DOI
  • Széles, Ádám; Kubik, András; Váncsa, Szilárd; Grünwald, Viktor; Hadaschik, Boris; Ács, Nándor; Hegyi, Péter; Nyirády, Péter; Szarvas, Tibor
    Prognostic and predictive value of pre-treatment blood-based inflammatory biomarkers in patients with urothelial carcinoma treated with immune checkpoint inhibitors : A systematic review and meta-analysis
    In: Frontiers in Immunology, Jg. 16, 2025, 1554048
    DOI, Online Volltext (Open Access)
  • Kubik, András; das Virgens, Isabel Pinto Amorim; Varga, Nóra; Szabó, Anett; Keszthelyi, Attila; Fehérvári, Péter; Hegyi, Péter; Ács, Nándor; Nyirády, Péter; Szarvas, Tibor
    Radical Surgery Compared to Bladder-Preserving Approaches for Limited Stage Small-Cell Bladder Cancer : Systematic Review and Meta-Analysis
    In: Clinical Genitourinary Cancer, Jg. 23, 2025, Nr. 5, 102389
    DOI (Open Access)
  • Horváth, András; Blasszauer, Celia; Komka, Ida; Reibl, Dániel; Hadaschik, Boris; Fazekas, Tamás; Rajwa, Pawel; Soós, Àron; Valikovics, Anikó; Nyirády, Péter; Szarvas, Tibor
    Real-World Overall Survival Comparison of Enzalutamide and Abiraterone In First- and Second-Line Setting of Metastatic Castration-Resistant Prostate Cancer
    In: The Prostate, Jg. 85, 2025, Nr. 12, S. 1151 – 1154
    DOI (Open Access)
  • Ács, Júlia; Szabó, Anett; Fehérvári, Péter; Skribek, Benjamin; Cavalcante, Bianca Golzio Navarro; Váncsa, Szilárd; Romics, Miklós; Szarvas, Tibor; Nyirády, Péter; Ács, Nándor; Hegyi, Péter; Majoros, Attila
    Risk factors for vaginal wall erosion after pelvic organ prolapse surgery with implant : a systematic review and meta-analysis
    In: Scientific Reports, Jg. 15, 2025, Nr. 1, 40780
    DOI (Open Access)
  • Szarvas, Tibor; Kramer, Gero; Jagarlamudi, Kiran; Styrke, Johan; Linder, Stig
    Serum Markers as predictors for treatment benefit in castration-resistant prostate cancer
    In: Urologic Oncology: Seminars and Original Investigations, Jg. 43, 2025, Nr. 11, S. 664.e11 – 664.e17
    DOI (Open Access)
  • Olah, Csilla; Sichward, Lara; Hadaschik, Boris; Darr, Christopher; Grünwald, Viktor; Krafft, Ulrich; Grünwald, Barbara; Mahmoud, Osama; Al-Nader, Mulham; Nyirady, Peter; Reis, Henning; Szarvas, Tibor
    Spatial distribution and subtype-specific expression patterns of Nectin-4 in muscle-invasive bladder cancer
    In: BJU International (BJUI), Jg. 136, 2025, Nr. 2, S. 297 – 305
    DOI (Open Access)
  • Al-Nader, Mulham; Krafft, Ulrich; Heß, Jochen A.; Püllen, Lukas; Szarvas, Tibor; Tschirdewahn, Stephan; Hadaschik, Boris; Mahmoud, Osama
    Temporal patterns of major postoperative events after radical cystectomy : Analysis of 90-day morbidity
    In: World Journal of Urology, Jg. 43, 2025, Nr. 1, 111
    DOI
  • Paner, Gladell P.; Al-Ahmadie, Hikmat; Gaisa, Nadine T.; Lopez-Beltran, Antonio; Maclean, Fiona; Tsuzuki, Toyonori; Werneck Da Cunha, Isabela; Amin, Mahul B.; Aning, Jonathan; Aron, Manju; Athanazio, Daniel; Bambury, Richard M.; Cheng, Liang; Gopalan, Anuradha; Gulmann, Christian; Guo, Charles C.; Harris, Carole; Iyer, Gopa; Jimenez, Rafael E.; Jinzaki, Masahiro; Kikuchi, Eiji; Lal, Priti; Miyai, Kosuke; Netto, George J.; Pan, Chin-Chen; Panebianco, Valeria; Van Rhijn, Bas WG; Siefker-Radtke, Arlene; Smith, Steven C.; Szarvas, Tibor; Wobker, Sara E.; Kristiansen, Glen; Reis, Henning; Algaba, Ferran; Barrett, Ciara; Bertz, Simone; Bezerra, Stephania M.; Birbe, Ruth; Chaudhri, Preeti; Cho, Yong Mee; Cimadamore, Alessia; Downes, Michelle R.; Elgeredly, Nadine; Fleischmann, Achim; Haider, Aiman; Hallam, Lavinia Ann; Hartmann, Arndt; Hatimy, Umi; Herrera, Loren; Huang, Jiaoti; Jufe, Laura; Kaushal, Seema; Kenny, Sarah; Lee, Hojung; Leite, Katia; Mayer, Nick; Mccormick, Christina; Mchale, Teresa; Montironi, Rodolfo; O'Donnell, Marie; Park, Yang Soon; Picken, Maria; Sanguedolce, Francesca; Shah, Nigam; Srigley, John; Sauter, Guido; Suzigan, Sueli; Swarbrick, Nicole; Theodosiou, Matthew; Tretriakova, Maria; Trias, Isabel; Lopez, Funda Vakar; Van Leenders, Geert; Vlatkovic, Ljiljana; Wang, Gang; Wightman, Daniela; Wightman, Robert H; Williamson, Sean R.; Ye, Huihui; Zhang, Hong
    The Dublin International Society of Urological Pathology (ISUP) Consensus Conference on Best Practice Recommendations on the Pathology of Glandular Lesions of the Urinary Bladder
    In: Advances in Anatomic Pathology, 2025, in press
    DOI
  • Reis, Henning; Al-Ahmadie, Hikmat; Gaisa, Nadine T.; Lopez-Beltran, Antonio; Maclean, Fiona; Tsuzuki, Toyonori; Werneck Da Cunha, Isabela; Amin, Mahul B.; Aning, Jonathan; Aron, Manju; Athanazio, Daniel; Bambury, Richard M.; Cheng, Liang; Gopalan, Anuradha; Gulmann, Christian; Guo, Charles C.; Harris, Carole; Iyer, Gopa; Jimenez, Rafael E.; Jinzaki, Masahiro; Kikuchi, Eiji; Lal, Priti; Miyai, Kosuke; Netto, George J.; Pan, Chin-Chen; Panebianco, Valeria; Van Rhijn, Bas Wg; Siefker-Radtke, Arlene; Smith, Steven C.; Szarvas, Tibor; Wobker, Sara E.; Kristiansen, Glen; Paner, Gladell P.; Ferran, Algaba; Ciara, Barrett; Simone, Bertz; Bezerra Stephania, M.; Ruth, Birbe; Preeti, Chaudhri; Mee, Cho Yong; Alessia, Cimadamore; Downes, Michelle R.; Nadine, Elgeredly; Achim, Fleischmann; Aiman, Haider; Ann, Hallam Lavinia; Arndt, Hartmann; Umi, Hatimy; Loren, Herrera; Jiaoti, Huang; Gopa, Iyer; Laura, Jufe; Seema, Kaushal; Sarah, Kenny; Hojung, Lee; Katia, Leite; Nick, Mayer; Christina, McCormick; Teresa, McHale; Rodolfo, Montironi; Marie, O'Donnell; Soon, Park Yang; Maria, Picken; Francesca, Sanguedolce; Nigam, Shah; John, Srigley; Guido, Sauter; Sueli, Suzigan; Nicole, Swarbrick; Matthew, Theodosiou; Maria, Tretiakova; Isabel, Trias; Funda, Vakar Lepez; Van Leenders, Geert; Ljiljana, Vlatkovic; Gang, Wang; Daniela, Wightman; Wightman, Robert H.; Williamson, Sean R.; Huihui, Ye; Hong, Zhang
    The Dublin International Society of Urological Pathology (ISUP) Consensus Conference on Best Practice Recommendations on the Pathology of Urachal Neoplasms
    In: The American Journal of Surgical Pathology, Jg. 49, 2025, Nr. 11, S. e18 – e26
    DOI (Open Access)
  • Szalontai, János; Szarvas, Tibor; Miszczyk, Marcin; Nyirády, Péter; Shariat, Shahrokh F.; Fazekas, Tamás
    Toxicities of PARP inhibitors in genitourinary cancers
    In: Current Opinion in Urology, Jg. 35, 2025, Nr. 4, S. 467 – 471
    DOI (Open Access)
  • Szarvas, Tibor; Reis, Henning
    Beyond driver mutations : Exploring the landscape of mutational signatures in adenocarcinomas of the bladder
    In: The Journal of Pathology, Jg. 263, 2024, Nr. 4-5, S. 400 – 402
    DOI (Open Access)
  • Murtola, Teemu J.; Siltari, Aino; Raittinen, Paavo; Tammela, Teuvo L.J.; Linder, Stig; Csizmarik, Anita; Kramer, Gero; Szarvas, Tibor
    Elevated Levels of Serum Thymidine Kinase 1 Predict Poor Survival for Patients with Metastatic Prostate Cancer
    In: European Urology Open Science, Jg. 70, 2024, S. 135 – 141
    DOI (Open Access)
  • Olah, Csilla; Kubik, András; Mátrai, Péter; Engh, Marie Anne; Barna, Viktória; Hegyi, Péter; Reis, Henning; Nyirády, Péter; Szarvas, Tibor
    Estimation of the incidence of urachal cancer : A systematic review and meta-analysis of registry-based studies
    In: Urologic Oncology: Seminars and Original Investigations, Jg. 42, 2024, Nr. 7, S. 221.e1 – 221.e7
    DOI (Open Access)
  • Koll, Florestan Johannes; Weers, Lillian; Weigert, Andreas; Banek, Severine; Köllermann, Jens; Kluth, Luis; Wenzel, Mike; Garcia, Cristina Cano; Szarvas, Tibor; Wessolly, Michael; Ingenwerth, Marc; Jeroch, Jan; Döring, Claudia; Chun, Felix K.-H.; Wild, Peter J.; Reis, Henning
    Histopathologic, Molecular, and Clinical Profiling of Lymphoepithelioma-like Carcinoma of the Bladder
    In: Modern Pathology, Jg. 37, 2024, Nr. 11, 100588
    DOI (Open Access)
  • Filipov, Teodóra; Teutsch, Brigitta; Szabó, Anett; Forintos, Attila; Ács, Júlia; Váradi, Alex; Hegyi, Péter; Szarvas, Tibor; Ács, Nándor; Nyirády, Péter; Deák, Pál Ákos
    Investigating the role of ultrasound-based shear wave elastography in kidney transplanted patients : correlation between non-invasive fibrosis detection, kidney dysfunction and biopsy results ; a systematic review and meta-analysis
    In: Journal of Nephrology (JN), Jg. 37, 2024, Nr. 6, S. 1509 – 1522
    DOI (Open Access)
  • Fazekas, Tamás; Shim, Sung Ryul; Basile, Giuseppe; Baboudjian, Michael; Kói, Tamás; Przydacz, Mikolaj; Abufaraj, Mohammad; Ploussard, Guillaume; Kasivisvanathan, Veeru; Rivas, Juan Gómez; Gandaglia, Giorgio; Szarvas, Tibor; Schoots, Ivo G.; Van Den Bergh, Roderick C. N.; Leapman, Michael S.; Nyirády, Péter; Shariat, Shahrokh F.; Rajwa, Pawel
    Magnetic Resonance Imaging in Prostate Cancer Screening : A Systematic Review and Meta-Analysis
    In: JAMA Oncology, Jg. 10, 2024, Nr. 6, S. 745 – 754
    DOI, Online Volltext (Open Access)
  • Püllen, Lukas; Costa, Pedro F.; Darr, Christopher; Heß, Jochen A.; Kesch, Claudia; Rehme, Christian R.; Wahl, Milan; Yirga, Leubet; Reis, Henning; Szarvas, Tibor; van Leeuwen, Fijs W. B.; Herrmann, Ken; Hadaschik, Boris; Tschirdewahn, Stephan; Krafft, Ulrich
    Near-infrared fluorescence lymph node template region dissection plus backup lymphadenectomy in open radical cystectomy for bladder cancer using an innovative handheld device : A single center experience
    In: Journal of Surgical Oncology, Jg. 129, 2024, Nr. 7, S. 1325 – 1331
    DOI (Open Access)
  • Fazekas, Tamás; Széles, Ádám D; Teutsch, Brigitta; Csizmarik, Anita; Vékony, Bálint; Kói, Tamás; Ács, Nándor; Hegyi, Péter; Hadaschik, Boris; Nyirády, Péter; Szarvas, Tibor
    Poly (ADP-ribose) Polymerase Inhibitors Have Comparable Efficacy with Platinum Chemotherapy in Patients with BRCA-positive Metastatic Castration-resistant Prostate Cancer : A Systematic Review and Meta-analysis
    In: European Urology Oncology, Jg. 7, 2024, Nr. 3, S. 365 – 375
    DOI (Open Access)
  • Juhász, Dániel; Csizmarik, Anita; Szalontai, János; Keszthelyi, Attila; Dér, Bálint; Kubik, András; Szűcs, Miklós; Kenessey, István; Ertl, Iris E.; Berger, Walter; Englinger, Bernhard; Shariat, Shahrokh F.; Nyirády, Péter; Szarvas, Tibor
    Precision Oncology Approach for Urachal Carcinoma : A Clinical Case Report
    In: International Journal of Molecular Sciences (IJMS), Jg. 25, 2024, Nr. 24, 13315
    DOI (Open Access)
  • Ács, Júlia; Szabó, Anett; Fehérvári, Péter; Harnos, Andrea; Skribek, Benjamin; Tenke, Martin; Szarvas, Tibor; Nyirády, Péter; Ács, Nándor; Hegyi, Péter; Majoros, Attila
    Safety and Efficacy of Vaginal Implants in Pelvic Organ Prolapse Surgery : A Meta-analysis of 161 536 Patients
    In: European Urology Focus, Jg. 10, 2024, Nr. 4, S. 525 – 534
    DOI (Open Access)
  • Reis, Henning; Al-Ahmadie, Hikmat; Szarvas, Tibor; Grünwald, Viktor; Köllermann, Jens; Koll, Florestan; Hadaschik, Boris; Chun, Felix; Wild, Peter J.; Paner, Gladell P.
    Seltenere Tumoren und Tumortypen des ableitenden Harnsystems in der 5. Aufl. der WHO-Klassifikation 2022
    In: Die Pathologie, Jg. 45, 2024, Nr. 6, S. 381 – 388
    DOI
  • Varadi, Melinda; Nagy, Nikolett; Reis, Henning; Hadaschik, Boris; Niedworok, Christian; Modos, Orsolya; Szendroi, Attila; Ablat, Jason; Black, Peter C.; Keresztes, David; Csizmarik, Anita; Olah, Csilla; Gaisa, Nadine T.; Kiss, Andras; Timar, Jozsef; Toth, Erika; Csernak, Erzsebet; Gerstner, Arpad; Mittal, Vinay; Karkampouna, Sofia; Kruithof de Julio, Marianna; Gyorffy, Balazs; Bedics, Gabor; Rink, Michael; Fisch, Margit; Nyirady, Peter; Szarvas, Tibor
    Clinical sequencing identifies potential actionable alterations in a high rate of urachal and primary bladder adenocarcinomas
    In: Cancer Medicine, Jg. 12, 2023, Nr. 7, S. 9041 – 9054
    DOI (Open Access)
  • Csizmarik, Anita; Nagy, Nikolett; Keresztes, Dávid; Váradi, Melinda; Bracht, Thilo; Sitek, Barbara; Witzke, Kathrin; Puhr, Martin; Tornyi, Ilona; Lázár, József; Takács, László; Kramer, Gero; Sevcenco, Sabina; Maj-Hes, Agnieszka; Hadaschik, Boris; Nyirády, Péter; Szarvas, Tibor
    Comparative proteome and serum analysis identified FSCN1 as a marker of abiraterone resistance in castration-resistant prostate cancer
    In: Prostate Cancer and Prostatic Diseases, Jg. 27, 2023, Nr. 3, S. 451 – 456
    DOI (Open Access)
  • Kubik, András; das Virgens, Isabel Pinto Amorim; Szabó, Anett; Váradi, Melinda; Csizmarik, Anita; Keszthelyi, Attila; Majoros, Attila; Fehérvári, Péter; Hegyi, Péter; Ács, Nándor; Nyirády, Péter; Szarvas, Tibor
    Comprehensive Analysis of the Prognostic Value of Circulating MMP-7 Levels in Urothelial Carcinoma : A Combined Cohort Analysis, Systematic Review, and Meta-Analysis
    In: International Journal of Molecular Sciences (IJMS), Jg. 24, 2023, Nr. 9, 7859
    DOI (Open Access)
  • Szarvas, Tibor
    Editorial Comment to Identification of tumor immunophenotypes associated with immunotherapy response in bladder cancer
    In: International Journal of Urology, Jg. 30, 2023, Nr. 12, S. 1132 – 1133
    DOI (Open Access)
  • Váradi, Melinda; Horváth, Orsolya; Módos, Orsolya; Fazekas, Tamás; Grunewald, Camilla M.; Niegisch, Günter; Krafft, Ulrich; Grünwald, Viktor; Hadaschik, Boris; Olah, Csilla; Maráz, Anikó; Furka, Andrea; Szűcs, Miklós; Nyirády, Péter; Szarvas, Tibor
    Efficacy of immune checkpoint inhibitor therapy for advanced urothelial carcinoma in real-life clinical practice : results of a multicentric, retrospective study
    In: Scientific Reports, Jg. 13, 2023, Nr. 1, 17378
    DOI (Open Access)
  • Szabó, Anett; Váncsa, Szilárd; Hegyi, Péter; Váradi, Alex; Forintos, Attila; Filipov, Teodóra; Ács, Júlia; Ács, Nándor; Szarvas, Tibor; Nyirády, Péter; Kopa, Zsolt
    Lifestyle-, environmental-, and additional health factors associated with an increased sperm DNA fragmentation : A systematic review and meta-analysis
    In: Reproductive Biology and Endocrinology, Jg. 21, 2023, Nr. 1, 5
    DOI (Open Access)
  • Koll, Florestan J.; Döring, Claudia; Olah, Csilla; Szarvas, Tibor; Köllermann, Jens; Hoeh, Benedikt; Chun, Felix K.-H.; Reis, Henning; Wild, Peter J.
    Optimizing identification of consensus molecular subtypes in muscle-invasive bladder cancer : a comparison of two sequencing methods and gene sets using FFPE specimens
    In: BMC Cancer, Jg. 23, 2023, Nr. 1, 504
    DOI (Open Access)
  • Széles, Ádám; Fazekas, Tamás; Váncsa, Szilard; Váradi, Melinda; Kovács, Petra Terézia; Krafft, Ulrich; Grünwald, Viktor; Hadaschik, Boris; Csizmarik, Anita; Hegyi, Péter; Váradi, Alex; Nyirády, Péter; Szarvas, Tibor
    Pre-treatment soluble PD-L1 as a predictor of overall survival for immune checkpoint inhibitor therapy : a systematic review and meta-analysis
    In: Cancer Immunology, Immunotherapy, Jg. 72, 2023, Nr. 5, S. 1061 – 1073
    DOI (Open Access)
  • Olah, Csilla; Reis, Henning; Hoffmann, Michèle J.; Mairinger, Fabian; Ting, Saskia; Hadaschik, Boris; Krafft, Ulrich; Grünwald, Viktor; Nyirady, Peter; Varadi, Melinda; Győrffy, Balázs; Kiss, Andras; Szekely, Eszter; Sjödahl, Gottfrid; Szarvas, Tibor
    Predictive value of molecular subtypes and APOBEC3G for adjuvant chemotherapy in urothelial bladder cancer
    In: Cancer Medicine, Jg. 12, 2023, Nr. 5, S. 5222 – 5232
    DOI, Online Volltext (Open Access)
  • Njouendou, Abdel Jelil; Szarvas, Tibor; Tiofack, Arnol Auvaker Zebaze; Kenfack, Rovaldo Nguims; Tonouo, Pamela Derliche; Ananga, Sidonie Noa; Bell, Esther H M Dina; Simo, Gustave; Hoheisel, Jörg D; Siveke, Jens T.; Lueong, Smiths S.
    SOX2 dosage sustains tumor-promoting inflammation to drive disease aggressiveness by modulating the FOSL2/IL6 axis
    In: Molecular Cancer, Jg. 22, 2023, Nr. 1, 52
    DOI, Online Volltext (Open Access)
  • Fazekas, Tamás; Széles, Ádám D.; Teutsch, Brigitta; Csizmarik, Anita; Vékony, Bálint; Váradi, Alex; Kói, Tamás; Lang, Zsolt; Ács, Nándor; Kopa, Zsolt; Hegyi, Péter; Hadaschik, Boris; Grünwald, Viktor; Nyirády, Péter; Szarvas, Tibor
    Therapeutic sensitivity to standard treatments in BRCA positive metastatic castration-resistant prostate cancer patients : A systematic review and meta-analysis
    In: Prostate Cancer and Prostatic Diseases, Jg. 26, 2023, Nr. 4, S. 665 – 672
    DOI (Open Access)
  • Olah, Csilla; Hahnen, Christina; Nagy, Nikolett; Musial, Joanna; Varadi, Melinda; Nyiro, Gabor; Gyorffy, Balazs; Hadaschik, Boris; Rawitzer, Josefine; Ting, Saskia; Sjödahl, Gottfrid; Hoffmann, Michéle J.; Reis, Henning; Szarvas, Tibor
    A quantitative polymerase chain reaction based method for molecular subtype classification of urinary bladder cancer : Stromal gene expressions show higher prognostic values than intrinsic tumor genes
    In: International Journal of Cancer, Jg. 150, 2022, Nr. 5, S. 856 – 867
    DOI (Open Access)
  • Rehme, Christian R.; Fritsch, Beatrix; Thomas, Luca; Istin, Stefan; Burchert, Carolin; Hummel, Bastian; Baleanu-Curaj, Bogdan; Reis, Henning; Szarvas, Tibor; Rübben, Herbert; Hadaschik, Boris; Niedworok, Christian
    Clinical outcome and quality of life in octogenarian patients with muscle-invasive urothelial carcinoma of the bladder treated with radical cystectomy or transurethral resection of the bladder tumor : a retrospective analysis of 143 patients
    In: International Urology and Nephrology, Jg. 54, 2022, Nr. 1, S. 71 – 79
    DOI (Open Access)
  • Szarvas, Tibor; Reis, Henning
    Commentary: Treatment Outcome of Different Chemotherapy in Patients With Relapsed or Metastatic Malignant Urachal Tumor
    In: Frontiers in Oncology, Jg. 12, 2022, 864708
    DOI (Open Access)
  • Krafft, Ulrich; Mahmoud, O.; Heß, Jochen A.; Radtke, Jan Phillipp; Panic, Andrej; Püllen, Lukas; Darr, Christopher; Kesch, C.; Szarvas, Tibor; Rehme, Christian R.; Hadaschik, Boris; Tschirdewahn, Stephan
    Comparative analysis of Bricker versus Wallace ureteroenteric anastomosis and identification of predictors for postoperative ureteroenteric stricture
    In: Langenbeck's Archives of Surgery, Jg. 407, 2022, Nr. 3, S. 1233 – 1240
    DOI (Open Access)
  • Keresztes, Dávid; Csizmarik, Anita; Nagy, Nikolett; Módos, Orsolya; Fazekas, Tamás; Bracht, Thilo; Sitek, Barbara; Witzke, Kathrin; Puhr, Martin; Sevcenco, Sabina; Kramer, Gero; Shariat, Shahrokh; Küronya, Zsófia; Takács, László; Tornyi, Ilona; Lázár, József; Hadaschik, Boris; Lászik, András; Szűcs, Miklós; Nyirády, Péter; Szarvas, Tibor
    Comparative proteome analysis identified CD44 as a possible serum marker for docetaxel resistance in castration-resistant prostate cancer
    In: Journal of Cellular and Molecular Medicine, Jg. 26, 2022, Nr. 4, S. 1332 – 1337
    DOI (Open Access)
  • Kovács, Petra Terézia; Mayer, Tamás; Csizmarik, Anita; Váradi, Melinda; Oláh, Csilla; Széles, Ádám; Tschirdewahn, Stephan; Krafft, Ulrich; Hadaschik, Boris; Nyirády, Péter; Riesz, Péter; Szarvas, Tibor
    Elevated Pre-Treatment Serum MMP-7 Levels Are Associated with the Presence of Metastasis and Poor Survival in Upper Tract Urothelial Carcinoma
    In: Biomedicines, Jg. 10, 2022, Nr. 3, 698
    DOI, Online Volltext (Open Access)
  • Tóth, Gábor; Sugár, Simon; Pál, Domonkos; Fügedi, Kata Dorina; Drahos, László; Schlosser, Gitta; Oláh, Csilla; Reis, Henning; Kovalszky, Ilona; Szarvas, Tibor; Turiák, Lilla
    Glycosaminoglycan Analysis of FFPE Tissues from Prostate Cancer and Benign Prostate Hyperplasia Patients Reveals Altered Regulatory Functions and Independent Markers for Survival
    In: Cancers, Jg. 14, 2022, Nr. 19, 4867
    DOI (Open Access)
  • Széles, Ádám; Kovács, Petra Terézia; Csizmarik, Anita; Váradi, Melinda; Riesz, Péter; Fazekas, Tamás; Váncsa, Szilárd; Hegyi, Péter; Oláh, Csilla; Tschirdewahn, Stephan; Darr, Christopher; Krafft, Ulrich; Grünwald, Viktor; Hadaschik, Boris; Horváth, Orsolya; Nyirády, Péter; Szarvas, Tibor
    High Pretreatment Serum PD-L1 Levels Are Associated with Muscle Invasion and Shorter Survival in Upper Tract Urothelial Carcinoma
    In: Biomedicines, Jg. 10, 2022, Nr. 10, 2560
    DOI (Open Access)
  • Wessolly, Michael; Mairinger, Fabian D.; Herold, Thomas; Hadaschik, Boris; Szarvas, Tibor; Reis, Henning
    Proteasomal Processing Immune Escape Mechanisms in Platinum-Treated Advanced Bladder Cancer
    In: Genes, Jg. 13, 2022, Nr. 3, 422
    DOI (Open Access)
  • Csizmarik, Anita; Keresztes, Dávid; Nagy, Nikolett; Bracht, Thilo; Sitek, Barbara; Witzke, Kathrin; Puhr, Martin; Tornyi, Ilona; Lázár, József; Takács, László; Kramer, Gero; Sevcenco, Sabina; Maj-Hes, Agnieszka; Jurányi, Zsolt; Hadaschik, Boris; Nyirády, Péter; Szarvas, Tibor
    Proteome profiling of enzalutamide-resistant cell lines and serum analysis identified ALCAM as marker of resistance in castration-resistant prostate cancer
    In: International Journal of Cancer, Jg. 151, 2022, Nr. 8, S. 1405 – 1419
    DOI (Open Access)
  • Püllen, Lukas; Kaspar, Cordelia; Panic, Andrej; Heß, Jochen A.; Reis, Henning; Szarvas, Tibor; Radtke, Jan Philipp; Krafft, Ulrich; Darr, Christopher; Hadaschik, Boris; Tschirdewahn, Stephan
    Retrograde Pyelography in the Presence of Urothelial Bladder Cancer Does Not Affect the Risk of Upper Tract Urothelial Cancer : A Retrospective Analysis of a Single-Centre Cohort
    In: Urologia Internationalis, Jg. 106, 2022, S. 638 – 643
    DOI
  • Ingenwerth, Marc; Nyirády, Péter; Hadaschik, Boris; Szarvas, Tibor; Reis, Henning
    The Prognostic Value of Cytokeratin and Extracellular Collagen Expression in Urinary Bladder Cancer
    In: Current Molecular Medicine, Jg. 22, 2022, Nr. 10, S. 941 – 949
    DOI
  • Neumann, Judith Martha; Niehaus, Karsten; Neumann, Nils; Knobloch, Hans Christoph; Bremmer, Felix; Krafft, Ulrich; Kellner, Udo; Nyirády, Peter; Szarvas, Tibor; Bednarz, Hanna; Reis, Henning
    A new technological approach in diagnostic pathology : Mass spectrometry imaging-based metabolomics for biomarker detection in urachal cancer
    In: Laboratory Investigation, Jg. 101, 2021, Nr. 9, S. 1281 – 1288
    DOI (Open Access)
  • Szarvas, Tibor; Csizmarik, Anita; Fazekas, Tamás; Hüttl, András; Nyirády, Péter; Hadaschik, Boris; Grünwald, Viktor; Püllen, Lukas; Jurányi, Zsolt; Kocsis, Zsuzsa; Shariat, Shahrokh F.; Sevcenco, Sabina; Maj-Hes, Agnieszka; Kramer, Gero
    Comprehensive analysis of serum chromogranin A and neuron-specific enolase levels in localized and castration-resistant prostate cancer
    In: BJU International (BJUI), Jg. 127, 2021, Nr. 1, S. 44 – 55
    DOI
  • Fazekas, Tamás; Szarvas, Tibor; Csizmarik, Anita; Hadaschik, Boris; Nyirády, Péter
    Correction to : COVID-19 research ; promising tracks leading to uro-oncology
    In: International Urology and Nephrology, Jg. 53, 2021, Nr. 1, S. 95
    DOI (Open Access)
  • Neumann, Judith Martha; Niehaus, Karsten; Neumann, Nils; Knobloch, Hans Christoph; Bremmer, Felix; Krafft, Ulrich; Kellner, Udo; Nyirády, Peter; Szarvas, Tibor; Bednarz, Hanna; Reis, Henning
    Correction to: : A new technological approach in diagnostic pathology: mass spectrometry imaging-based metabolomics for biomarker detection in urachal cancer
    In: Laboratory Investigation, Jg. 101, 2021, Nr. 10, S. 1414
    DOI (Open Access)
  • Staniszewska, Magdalena; Fragoso Costa, Pedro; Eiber, Matthias; Klose, Jasmin M.; Wosniack, Jasmin; Reis, Henning; Szarvas, Tibor; Hadaschik, Boris; Lückerath, Katharina; Herrmann, Ken; Fendler, Wolfgang; Iking, Janette
    Enzalutamide enhances psma expression of psma-low prostate cancer
    In: International Journal of Molecular Sciences (IJMS), Jg. 22, 2021, Nr. 14, 7431
    DOI, Online Volltext (Open Access)
  • Kesch, Claudia; Yirga, Leubet; Dendl, Katharina; Handke, Analena; Darr, Christopher; Krafft, Ulrich; Radtke, Jan Philipp; Tschirdewahn, Stephan; Szarvas, Tibor; Fazli, Ladan; Gleave, Martin; Giesel, Frederik L.; Haberkorn, Uwe; Hadaschik, Boris
    High fibroblast-activation-protein expression in castration-resistant prostate cancer supports the use of FAPI-molecular theranostics
    In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 49, 2021, S. 385 – 389
    DOI (Open Access)
  • Krafft, Ulrich; Olah, Csilla; Reis, Henning; Kesch, Claudia; Darr, Christopher; Grünwald, Viktor; Tschirdewahn, Stephan; Hadaschik, Boris; Horvath, Orsolya; Kenessey, Istvan; Nyirady, Peter; Varadi, Melinda; Modos, Orsolya; Csizmarik, Anita; Szarvas, Tibor
    High serum pd-l1 levels are associated with poor survival in urothelial cancer patients treated with chemotherapy and immune checkpoint inhibitor therapy
    In: Cancers, Jg. 13, 2021, Nr. 11, 2548
    DOI, Online Volltext (Open Access)
  • Reider, Balazs; Gacsi, Eszter; Jankovics, Hajnalka; Vonderviszt, Ferenc; Szarvas, Tibor; Guttman, Andras; Jarvas, Gabor
    Integrated workflow for urinary prostate specific antigen N-glycosylation analysis using sdAb partitioning and downstream capillary electrophoresis separation
    In: Analytica Chimica Acta, Jg. 1184, 2021, 338892
    DOI (Open Access)
  • Szarvas, Tibor; Hoffmann, Michèle J.; Olah, Csilla; Szekely, Eszter; Kiss, Andras; Hess, Jochen; Tschirdewahn, Stephan; Hadaschik, Boris; Grotheer, Vera; Nyirady, Peter; Csizmarik, Anita; Varadi, Melinda; Reis, Henning
    MMP-7 Serum and Tissue Levels Are Associated with Poor Survival in Platinum-Treated Bladder Cancer Patients
    In: Diagnostics, Jg. 11, 2021, Nr. 1, 48
    DOI, Online Volltext (Open Access)
  • Csizmarik, Anita; Hadaschik, Boris; Kramer, Gero; Nyirady, Peter; Szarvas, Tibor
    Mechanisms and markers of resistance to androgen signaling inhibitors in patients with metastatic castration-resistant prostate cancer
    In: Urologic Oncology: Seminars and Original Investigations, Jg. 39, 2021, Nr. 10, S. 728.e13 – 728.e24
    DOI (Open Access)
  • Ortiz-Brüchle, Nadina; Wucherpfennig, Sophie; Rose, Michael; Garczyk, Stefan; Bertz, Simone; Hartmann, Arndt; Reis, Henning; Szarvas, Tibor; Kiss, András; Bremmer, Felix; Golz, Reinhard; Knüchel, Ruth; Gaisa, Nadine T.
    Molecular characterization of muellerian tumors of the urinary tract
    In: Genes, Jg. 12, 2021, Nr. 6, 880
    DOI (Open Access)
  • Maj-Hes, Agnieszka; Szarvas, Tibor; Sevcenco, Sabina; Kramer, Gero
    Multiple Docetaxel Retreatments Without Prednisone for Metastatic Castration-Resistant Prostate Cancer in the Docetaxel-Only Era : Effects on PSA Kinetics and Survival
    In: Advances in Therapy, Jg. 38, 2021, Nr. 7, S. 3831 – 3841
    DOI (Open Access)
  • Darr, Christopher; Costa, Pedro Fragoso; Kesch, Claudia; Krafft, Ulrich; Püllen, Lukas; Harke, Nina; Heß, Jochen A.; Szarvas, Tibor; Haubold, Johannes; Reis, Henning; Fendler, Wolfgang; Herrmann, Ken; Radtke, Jan Philipp; Hadaschik, Boris; Tschirdewahn, Stephan
    Prostate specific membrane antigen-radio guided surgery using Cerenkov luminescence imaging : Utilization of a short-pass filter to reduce technical pitfalls
    In: Translational Andrology and Urology, Jg. 10, 2021, Nr. 10, S. 3972 – 3985
    DOI (Open Access)
  • Harke, Nina N.; Darr, Christopher; Radtke, Jan Philipp; von Ostau, Nicola; Schiefelbein, Frank; Eraky, Ahmed; Hamann, Claudius; Szarvas, Tibor; Hadaschik, Boris; Tropmann-Frick, Marina; Juenemann, Klaus-Peter; Schoen, Georg; Osmonov, Daniar
    Retroperitoneal Versus Transperitoneal Robotic Partial Nephrectomy : A Multicenter Matched-pair Analysis
    In: European Urology Focus, Jg. 7, 2021, Nr. 6, S. 1363 – 1370
    DOI
  • Rehme, Christian R.; Burchert, Carolin; Tosun, Mustafa; Szarvas, Tibor; Nagy, Nadine; Rübben, Herbert; Hadaschik, Boris; Niedworok, Christian
    Stone extraction with loop ureteral catheter versus ureteroscopy in small distal ureteral stones—retrospective comparison of 547 consecutive patients
    In: Translational Andrology and Urology, Jg. 10, 2021, Nr. 1, S. 87 – 95
    DOI (Open Access)
  • Szarvas, Tibor; Csizmarik, Anita; Váradi, M.; Fazekas, Tamás; Hüttl, András Béla; Nyirády, Péter; Hadaschik, Boris; Grünwald, Viktor; Tschirdewahn, Stephan; Shariat, Shahrokh F.; Sevcenco, Sabina; Maj-Hes, Agnes B.; Kramer, Gero
    The prognostic value of serum MMP-7 levels in prostate cancer patients who received docetaxel, abiraterone, or enzalutamide therapy
    In: Urologic Oncology: Seminars and Original Investigations, Jg. 39, 2021, Nr. 5, S. 296.e11 – 296.e19
    DOI (Open Access)
  • Szarvas, Tibor; Reis, Henning
    Editorial Comment from Dr Szarvas and Dr Reis to Clinicopathological features of malignant urachal tumor : A hospital-based cancer registry data in Japan
    In: International Journal of Urology, Jg. 27, 2020, Nr. 2, S. 163 – 164
    DOI
  • Nini, Alessandro; Hoffmann, Michèle Janine; Lampignano, Rita; große Siemer, Robert; van Dalum, Guus; Szarvas, Tibor; Cotarelo, Cristina Lopez; Schulz, Wolfgang Arthur; Niederacher, Dieter; Neubauer, Hans; Stoecklein, Nikolas Hendrik; Niegisch, Günter
    Evaluation of HER2 expression in urothelial carcinoma cells as a biomarker for circulating tumor cells
    In: Cytometry Part B: Clinical Cytometry, Jg. 98, 2020, Nr. 4, S. 355 – 367
    DOI (Open Access)
  • Krafft, Ulrich; Reis, Henning; Ingenwerth, Marc; Kovalszky, Ilona; Becker, Markus; Niedworok, Christian; Darr, Christopher; Nyirády, Péter; Hadaschik, Boris; Szarvas, Tibor
    Nuclear Localization of Robo is Associated with Better Survival in Bladder Cancer
    In: Pathology & Oncology Research, Jg. 26, 2020, Nr. 1, S. 253 – 261
    DOI
  • Metzenmacher, Martin; Váraljai, Renáta; Hegedüs, Balazs; Cima, Igor; Forster, Jan; Schramm, Alexander; Scheffler, Björn; Horn, Peter; Klein, Christoph A.; Szarvas, Tibor; Reis, Henning; Bielefeld, Nicola; Rösch, Alexander; Aigner, Clemens; Kunzmann, Volker; Wiesweg, Marcel; Siveke, Jens T.; Schuler, Martin; Lueong, Smiths S.
    Plasma next generation sequencing and droplet digital-qpcr-based quantification of circulating cell-free rna for noninvasive early detection of cancer
    In: Cancers, Jg. 12, 2020, Nr. 2, 353
    DOI, Online Volltext (Open Access)
  • Nagy, Nikolett; Reis, Henning; Hadaschik, Boris; Niedworok, Christian; Módos, Orsolya; Szendrői, Attila; Bíró, Krisztina; Hager, Thomas; Herold, Thomas; Ablat, Jason; Black, Peter C.; Okon, Krzysztof; Tolkach, Yuri; Csizmarik, Anita; Oláh, Csilla; Keresztes, David; Bremmer, Felix; Gaisa, Nadine T.; Kriegsmann, Joerg; Kovalszky, Ilona; Kiss, András; Tímár, József; Szász, Marcell A.; Rink, Michael; Fisch, Margit; Nyirády, Péter; Szarvas, Tibor
    Prevalence of APC and PTEN Alterations in Urachal Cancer
    In: Pathology & Oncology Research, Jg. 26, 2020, Nr. 4, S. 2773 – 2781
    DOI (Open Access)
  • Krafft, Ulrich; Tschirdewahn, Stephan; Heß, Jochen A.; Harke, Nina; Hadaschik, Boris; Nyirády, Péter; Szendröi, Attila; Szücs, Miklós; Módos, Orsolya; Olah, Csilla; Székely, Eszter; Reis, Henning; Szarvas, Tibor
    STIP1 Tissue Expression Is Associated with Survival in Chemotherapy-Treated Bladder Cancer Patients
    In: Pathology & Oncology Research, Jg. 26, 2020, Nr. 2, S. 1243 – 1249
    DOI
  • Niedworok, Christian; Kempkensteffen, Carsten; Eisenhardt, Andreas; Tschirdewahn, Stephan; Rehme, Christian R.; Panic, Andrej; Reis, Henning; Baba, Hideo Andreas; Nyirády, Peter; Hadaschik, Boris; Kovalszky, Ilona; Szarvas, Tibor
    Serum and tissue syndecan-1 levels in renal cell carcinoma
    In: Translational Andrology and Urology, Jg. 9, 2020, Nr. 3, S. 1167 – 1176
    DOI (Open Access)
  • Olah, Csilla; Tschirdewahn, Stephan; Hoffmann, Michèle J.; Krafft, Ulrich; Hadaschik, Boris; Nyirady, Peter; Szendröi, Attila; Módos, Orsolya; Csizmarik, Anita; Kovalszky, Ilona; Reis, Henning; Szarvas, Tibor
    Soluble syndecan-1 levels are associated with survival in platinum-treated bladder cancer patients
    In: Diagnostics, Jg. 10, 2020, Nr. 11, 864
    DOI, Online Volltext (Open Access)
  • Hollósi, Péter; Váncza, Lóránd; Karászi, Katalin; Dobos, Katalin; Péterfia, Bálint; Tátrai, Enikő; Tátrai, Péter; Szarvas, Tibor; Paku, Sándor; Szilák, László; Kovalszky, Ilona
    Syndecan-1 promotes hepatocyte-like differentiation of hepatoma cells targeting ETS-1 and AP-1
    In: Biomolecules, Jg. 10, 2020, Nr. 10, 1356
    DOI (Open Access)
  • Hager, Thomas; Kraywinkel, Klaus; Szarvas, Tibor; Hadaschik, Boris; Schmid, Kurt Werner; Reis, Henning
    Urachal cancer in Germany and the USA : An RKI/SEER population-based comparison study
    In: Urologia Internationalis, Jg. 104, 2020, Nr. 9-10, S. 803 – 809
    DOI
  • Tschirdewahn, Stephan; Panic, Andrej; Püllen, Lukas; Harke, Nina; Hadaschik, Boris; Riesz, Peter; Horváth, Andras; Szalontai, Janos; Nyirády, Peter; Baba, Hideo Andreas; Reis, Henning; Szarvas, Tibor
    Circulating and tissue IMP3 levels are correlated with poor survival in renal cell carcinoma
    In: International Journal of Cancer, Jg. 145, 2019, Nr. 2, S. 531 – 539
    DOI
  • Maj-Hes, Agnieszka; Sevcenco, Sabina; Szarvas, Tibor; Kramer, Gero
    Claros System: A Rapid Microfluidics-Based Point-of-Care System for Quantitative Prostate Specific Antigen Analysis from Finger-Stick Blood
    In: Advances in Therapy, Jg. 36, 2019, Nr. 4, S. 916 – 922
    DOI
  • Reis, Henning; Mairinger, F.; Ting, Saskia; Nagy, N.; Witzke, K.E.; Kohl, M.; Sitek, B.; Niedworok, Christian; Hadaschik, Boris; Nyirády, P.; Szarvas, Tibor
    Das Urachuskarzinom : Ein Update aktueller molekularer Ergebnisse
    In: Der Pathologe, Jg. 40, 2019, Nr. Suppl. 3, S. 239 – 243
    DOI
  • Szarvas, Tibor; Jardin-Watelet, Bénédicte; Bourgoin, Nicolas; Hoffmann, Michèle J; Nyirady, Peter; Oláh, Csilla; Széll, Tamás; Csizmarik, Anita; Hadaschik, Boris; Reis, Henning
    High soluble CGA levels are associated with poor survival in bladder cancer
    In: Endocrine Connections, Jg. 8, 2019, Nr. 5, S. 625 – 633
    DOI, Online Volltext (Open Access)
  • Szarvas, Tibor; Olah, Csilla; Reis, Henning
    Neoadjuvant cisplatin-based chemotherapy in “primary” and “secondary” muscle-invasive bladder cancer—is it a surrogate for molecular subtypes?
    In: Translational Cancer Research, Jg. 8, 2019, Nr. Suppl. 2, S. 176 – S179
    DOI (Open Access)
  • Reis, Henning; Szarvas, Tibor; Grünwald, Viktor
    Prädiktive Biomarker in der onkologischen Uropathologie
    In: Der Pathologe, Jg. 40, 2019, Nr. 3, S. 264 – 275
    DOI
  • Reis, Henning; Szarvas, Tibor
    Therapieprädiktive Biomarker des Harnblasenkarzinoms
    In: Der Pathologe, Jg. 40, 2019, Nr. Suppl. 3, S. 331 – 338
    DOI
  • Reis, Henning; Szarvas, Tibor
    Urachal cancer : current concepts of a rare cancer
    In: Der Pathologe, Jg. 40, 2019, Nr. Suppl. 1, S. 31 – 39
    DOI
  • Krafft, Ulrich; Tschirdewahn, Stephan; Heß, Jochen A.; Harke, Nina N.; Hadaschik, Boris; Olah, Csilla; Krege, Susanne; Nyirády, Peter; Szendröi, Attila; Szücs, Miklós; Módos, Orsolya; Székely, Eszter; Reis, Henning; Szarvas, Tibor
    Validation of survivin and HMGA2 as biomarkers for cisplatin resistance in bladder cancer
    In: Urologic Oncology: Seminars and Original Investigations, Jg. 37, 2019, Nr. 11, S. 810.e7 – 810.e15
    DOI
  • Reis, Henning; Krafft, Ulrich; Niedworok, Christian; Módos, Orsolya; Herold, Thomas; Behrendt, Mark; Al-Ahmadie, Hikmat; Hadaschik, Boris; Nyirady, Peter; Szarvas, Tibor
    Biomarkers in Urachal Cancer and Adenocarcinomas in the Bladder : A Comprehensive Review Supplemented by Own Data
    In: Disease Markers, 2018, 7308168
    DOI (Open Access)
  • Szarvas, Tibor; Sevcenco, Sabina; Módos, Orsolya; Keresztes, Dávid; Nyirády, Péter; Kubik, András; Romics, Miklós; Kovalszky, Ilona; Reis, Henning; Hadaschik, Boris; Shariat, Shahrokh F.; Kramer, Gero
    Circulating syndecan-1 is associated with chemotherapy-resistance in castration-resistant prostate cancer
    In: Urologic Oncology: Seminars and Original Investigations, Jg. 36, 2018, Nr. 6, S. 312.e9 – 312.e15
    DOI, Online Volltext (Open Access)
  • Reis, Henning; Szarvas, Tibor
    Das Urachuskarzinom : aktuelle Konzepte einer seltenen Tumorerkrankung
    In: Der Pathologe, Jg. 39, 2018, Nr. Supplement 2, S. 291 – 300
    DOI
  • Szarvas, Tibor; Sevcenco, Sabina; Módos, Orsolya; Keresztes, Dávid; Nyirády, Péter; Csizmarik, Anita; Ristl, Robin; Puhr, Martin; Hoffmann, Michèle J.; Niedworok, Christian; Hadaschik, Boris; Maj-Hes, Agnieszka; Shariat, Shahrokh F.; Kramer, Gero
    Matrix metalloproteinase 7, soluble Fas and Fas ligand serum levels for predicting docetaxel resistance and survival in castration-resistant prostate cancer
    In: BJU International (BJUI), Jg. 122, 2018, Nr. 4, S. 695 – 704
    DOI, Online Volltext (Open Access)
  • Reis, Henning; van der Vos, Kristan E.; Niedworok, Christian; Herold, Thomas; Módos, Orsolya; Szendroi, Attila; Hager, Thomas; Ingenwerth, Marc; Vis, Daniël J.; Behrendt, Mark A.; de Jong, Jeroen; van der Heijden, Michiel S.; Peyronnet, Benoit; Mathieu, Romain; Wiesweg, Marcel; Ablat, Jason; Okon, Krzysztof; Tolkach, Yuri; Keresztes, David; Nagy, Nikolett; Bremmer, Felix; Gaisa, Nadine T.; Chlosta, Piotr; Kriegsmann, Joerg; Kovalszky, Ilona; Timar, József; Kristiansen, Glen; Radzun, Heinz-Joachim; Knüchel, Ruth; Schuler, Martin; Black, Peter C.; Rübben, Herbert; Hadaschik, Boris; Schmid, Kurt Werner; van Rhijn, Bas W.G.; Nyirády, Péter; Szarvas, Tibor
    Pathogenic and targetable genetic alterations in 70 urachal adenocarcinomas
    In: International Journal of Cancer, Jg. 143, 2018, Nr. 7, S. 1764 – 1773
    DOI, Online Volltext (Open Access)
  • Darr, Christopher; Krafft, Ulrich; Hadaschik, Boris; Tschirdewahn, Stephan; Sevcenco, Sabina; Csizmarik, Anita; Nyirady, Peter; Küronya, Zsófia; Reis, Henning; Maj-Hes, Agnieszka; Shariat, Shahrokh F.; Kramer, Gero; Szarvas, Tibor
    The Role of YKL-40 in Predicting Resistance to Docetaxel Chemotherapy in Prostate Cancer
    In: Urologia Internationalis, Jg. 101, 2018, Nr. 1, S. 65 – 73
    DOI
  • Fulop, Tibor; Zsom, Lajos; Rodriguez, Betzaida; Afshan, Sabahat; Davidson, Jamie V; Szarvas, Tibor; Dixit, Mehul; Tapolyai, Mihaly B; Rosivall, László
    Clinical Utility of Potassium-Sparing Diuretics to Maintain Normal Serum Potassium in Peritoneal Dialysis Patients
    In: Peritoneal Dialysis International, Jg. 37, 2017, Nr. 1, S. 63 – 69
    DOI
  • Droop, Johanna; Szarvas, Tibor; Schulz, Wolfgang A.; Niedworok, Christian; Niegisch, Günter; Scheckenbach, Kathrin; Hoffmann, Michèle J.
    Diagnostic and prognostic value of long noncoding RNAs as biomarkers in urothelial carcinoma
    In: PLoS ONE, Jg. 12, 2017, Nr. 4, S. e0176287
    DOI (Open Access)
  • Fullár, Alexandra; Firneisz, Gábor; Regős, Eszter; Dudás, József; Szarvas, Tibor; Baghy, Kornélia; Ramadori, Giuliano; Kovalszky, Ilona
    Response of Hepatic Stellate Cells to TGFB1 Differs from the Response of Myofibroblasts. Decorin Protects against the Action of Growth Factor
    In: Pathology & Oncology Research, Jg. 23, 2017, Nr. 2, S. 287 – 294
    DOI
  • Reis, Henning; Niedworok, Christian; Szarvas, Tibor
    Response to: Absence of GNAS and BRAF mutations but presence of KRAS mutation in urachal adenocarcinoma
    In: Pathology, Jg. 49, 2017, Nr. 5, S. 561 – 562
    DOI
  • Niedworok, Christian; Tschirdewahn, Stephan; Reis, Henning; Lehmann, Nils; Szücs, Miklós; Nyirády, Péter; Romics, Imre; Rübben, Herbert; Szarvas, Tibor
    Serum Chromogranin A as a Complementary Marker for the Prediction of Prostate Cancer-Specific Survival
    In: Pathology & Oncology Research, Jg. 23, 2017, Nr. 3, S. 643 – 650
    DOI
  • Thiem, Sebastian; Herold, Thomas; Krafft, Ulrich; Bremmer, Felix; Tolkach, Yuri; Szász, Attila M.; Kriegsmann, Joerg; Gaisa, Nadine T.; Niedworok, Christian; Szarvas, Tibor; Reis, Henning
    Telomerase reverse transcriptase (TERT) promoter mutations are rare in urachal cancer
    In: Pathology International, Jg. 67, 2017, Nr. 12, S. 597 – 601
    DOI
  • vom Dorp, Frank; Szarvas, Tibor; Rübben, Herbert; Nyirady, Peter; Shariat, Shahrokh F.; Kramer, Gero; Busch, Jonas; Kempkensteffen, Carsten; Krause, Hans; Reis, Henning; Niedworok, Christian; Tschirdewahn, Stephan
    Circulating and Tissue Expression Levels of YKL-40 in Renal Cell Cancer
    In: The Journal of Urology, Jg. 195, 2016, Nr. 4, S. 1120 – 1125
    DOI
  • Nyirády, Péter; Niedworok, Christian; Reis, Henning; Szarvas, Tibor
    Clinical Sequencing-guided Therapy of Urachal Carcinoma : New Perspective for a Rare Cancer
    In: European Urology, Jg. 70, 2016, Nr. 5, S. 776 – 777
    DOI
  • Szarvas, Tibor; Módos, Orsolya; Niedworok, Christian; Reis, Henning; Szendröi, Attila; Szász, Marcell A.; Nyirády, Péter
    Clinical, prognostic, and therapeutic aspects of urachal carcinoma—A comprehensive review with meta-analysis of 1,010 cases
    In: Urologic Oncology: Seminars and Original Investigations, Jg. 34, 2016, Nr. 9, S. 388 – 398
    DOI
  • Módos, Orsolya; Reis, Henning; Niedworok, Christian; Rübben, Herbert; Szendröi, Attila; Szász, Marcell A; Tímár, József; Baghy, Kornélia; Kovalszky, Ilona; Golabek, Tomasz; Chlosta, Piotr; Okon, Krzysztof; Peyronnet, Benoit; Mathieu, Romain; Shariat, Shahrokh F; Hollósi, Péter; Nyirády, Péter; Szarvas, Tibor
    Mutations of KRAS, NRAS, BRAF, EGFR, and PIK3CA genes in urachal carcinoma : Occurence and prognostic significance
    In: OncoTarget, Jg. 7, 2016, Nr. 26, S. 39293 – 39301
    DOI (Open Access)
  • Szarvas, Tibor; Reis, Henning; vom Dorp, Frank; Tschirdewahn, Stephan; Niedworok, Christian; Nyirady, Peter; Schmid, Kurt Werner; Rübben, Herbert; Kovalszky, Ilona
    Soluble syndecan-1 (SDC1) serum level as an independent pre-operative predictor of cancer-specific survival in prostate cancer
    In: The Prostate, Jg. 76, 2016, Nr. 11, S. 977 – 985
    DOI
  • Tapolyai, Mihály B; Faludi, Mária; Berta, Klára; Szarvas, Tibor; Lengvárszky, Zsolt; Molnar, Miklos Z; Dossabhoy, Neville R; Fülöp, Tibor
    The effect of ambient temperature and humidity on interdialytic weight gains in end-stage renal disease patients on maintenance hemodialysis
    In: International Urology and Nephrology, Jg. 48, 2016, Nr. 7, S. 1171 – 1176
    DOI
  • Niedworok, Christian; Panitz, Martin; Szarvas, Tibor; Reis, Henning; Reis, Anna Carinna; Szendröi, Attila; Nyirády, Peter; Marcell Szasz; Módos, Orsolya; Rübben, Herbert; vom Dorp, Frank
    Urachal Carcinoma of the Bladder: Impact of Clinical and Immunohistochemical Parameters on Prognosis
    In: The Journal of Urology, Jg. 195, 2016, Nr. 6, S. 1690 – 1695
    DOI
  • Niedworok, Christian; Szarvas, Tibor; Szucs, Miklos; Rübben, Herbert; Reis, Henning; Tschirdewahn, Stephan; vom Dorp, Frank
    Validation of the diagnostic and prognostic relevance of serum MMP-7 levels in renal cell cancer by using a novel automated fluorescent immunoassay method
    In: International Urology and Nephrology, Jg. 48, 2016, Nr. 3, S. 355 – 361
    DOI
  • Szarvas, Tibor; Módos, Orsolya; Horváth, András; Nyirády, Péter
    Why are upper tract urothelial carcinoma two different diseases?
    In: Translational Andrology and Urology, Jg. 5, 2016, Nr. 5, S. 636 – 647
    DOI (Open Access)
  • Acs, Balazs; Szarvas, Tibor; Szekely, Nora; Nyirady, Peter; Szasz, A Marcell
    Current State of ERG as Biomarker in Prostatic Adenocarcinoma
    In: Current Cancer Drug Targets, Jg. 15, 2015, Nr. 8, S. 643 – 651
    DOI
  • Niedworok, Christian; Dörrenhaus, Bettina; vom Dorp, Frank; Piotrowski, Jarowit Adam; Tschirdewahn, Stephan; Szarvas, Tibor; Rübben, Herbert; Schenck, Marcus
    Renal cell carcinoma and tumour thrombus in the inferior vena cava : clinical outcome of 98 consecutive patients and the prognostic value of preoperative parameters
    In: World Journal of Urology, Jg. 33, 2015, Nr. 10, S. 1541 – 1552
    DOI
  • Hoffmann, Michèle J.; Dehn, Judith; Droop, Johanna; Niegisch, Günter; Niedworok, Christian; Szarvas, Tibor; Schulz, Wolfgang A.
    Truncated Isoforms of lncRNA ANRIL Are Overexpressed in Bladder Cancer, But Do Not Contribute to Repression of INK4 Tumor Suppressors
    In: Non-Coding RNA, Jg. 1, 2015, Nr. 3, S. 266 – 284
    DOI (Open Access)
  • Szarvas, Tibor
    Editorial Comment from Dr Szarvas to Functional polymorphisms in the matrix metalloproteinase genes and their association with bladder cancer risk and recurrence : A mini-review
    In: International Journal of Urology, Jg. 21, 2014, Nr. 8, S. 753
    DOI
  • Szarvas, Tibor; Reis, Henning; Kramer, Gero; Shariat, Shahrokh F; vom Dorp, Frank; Tschirdewahn, Stephan; Schmid, Kurt Werner; Kovalszky, Ilona; Rübben, Herbert
    Enhanced stromal syndecan-1 expression is an independent risk factor for poor survival in bladder cancer
    In: Human Pathology, Jg. 45, 2014, Nr. 4, S. 674 – 682
    DOI
  • vom Dorp, Frank; Tschirdewahn, Stephan; Szarvas, Tibor; Rubben, H.; Kraemer, R.; Rehme, Christian R.
    Erratum zu : Urothelkarzinom der Harnblase. Organerhaltende Therapiestrategien
    In: Der Urologe, Jg. 53, 2014, Nr. 12, S. 1832
    DOI
  • Palacios, DiegoAguil; Chen, Limei; Dai, Yunfeng; Andersen, LarsDyrskj; Sanchez-Carbayo, Marta; Szarvas, Tibor; Zwarthoff, EllenC; Jeronimo, Carmen; Parker, AlexanderS; Ross, Shanti; Chai, KarlX; Goodison, Steve; Rosser, CharlesJ
    External validation of a multiplex urinary protein panel for the detection of bladder cancer in a multicenter cohort
    In: The Journal of Urology, Jg. 191, 2014, Nr. Suppl. 4, S. E235
    DOI
  • Chen, L.-M.; Chang, M.; Dai, Y.; Chai, K. X.; Dyrskjot, L.; Sanchez-Carbayo, M.; Szarvas, Tibor; Zwarthoff, E. C.; Lokeshwar, V.; Jeronimo, C.; Parker, A. S.; Ross, S.; Borre, M.; \Orntoft, T. F.; Jaeger, T.; Beukers, W.; Lopez, L. E.; Henrique, R.; Young, P. R.; Urquidi, V.; Goodison, S.; Rosser, C. J.
    External validation of a multiplex urinary protein panel for the detection of bladder cancer in a multicenter cohort
    In: Cancer Epidemiology, Biomarkers & Prevention, Jg. 23, 2014, Nr. 9, S. 1804 – 1812
    DOI
  • Tschirdewahn, Stephan; Reis, Henning; Niedworok, Christian; Nyirady, Peter; Szendröi, Attila; Schmid, Kurt Werner; Shariat, Shahrokh F.; Kramer, Gero; vom Dorp, Frank; Rübben, Herbert; Szarvas, Tibor
    Prognostic effect of serum and tissue YKL-40 levels in bladder cancer
    In: Urologic Oncology: Seminars and Original Investigations, Jg. 32, 2014, Nr. 5, S. 663 – 669
    DOI
  • Szarvas, Tibor; Tschirdewahn, Stephan; Niedworok, Christian; Kramer, Gero; Sevcenco, Sabina; Reis, Henning; Shariat, Shahrokh F.; Rübben, Herbert; vom Dorp, Frank
    Prognostic value of tissue and circulating levels of IMP3 in prostate cancer
    In: International Journal of Cancer, Jg. 135, 2014, Nr. 7, S. 1596 – 1604
    DOI (Open Access)
  • Szarvas, Tibor; Rübben, Herbert; Reis, Henning
    Re: Association of Oncofetal Protein Expression with Clinical Outcomes in Patients with Urothelial Carcinoma of the Bladder
    In: The Journal of Urology, Jg. 192, 2014, Nr. 2, S. 617 – 618
    DOI
  • vom Dorp, Frank; Tschirdewahn, Stephan; Szarvas, Tibor; Rübben, Herbert; Rehme, Christian R.
    Urothelkarzinom der Harnblase : Organerhaltende Therapiestrategien
    In: Der Urologe, Jg. 53, 2014, Nr. 9, S. 1322 – 1328
    DOI (Open Access)
  • Szarvas, Tibor
    Editorial comment to characterization and risk stratification of prostate cancer in patients undergoing radical cystoprostatectomy
    In: International Journal of Urology, Jg. 20, 2013, Nr. 9, S. 872
    DOI
  • Niedworok, Christian; Roc̈k, Katharina; Kretschmer, Inga; Freudenberger, Till; Nagy, Nadine; Szarvas, Tibor; vom Dorp, Frank; Reis, Henning; Rübben, Herbert; Fischer, Jens W.
    Inhibitory role of the small leucine-rich proteoglycan biglycan in bladder cancer
    In: PLoS ONE, Jg. 8, 2013, Nr. 11, S. e80084
    DOI (Open Access)
  • Jäger, Tobias; Tschirdewahn, Stephan; vom Dorp, Frank; Piechotta, G.; Rübben, Herbert; Szarvas, Tibor
    MMP-7-Bestimmung im Urin basierend auf Siliziumchiptechnologie : Eine Möglichkeit zur präoperativen Identifizierung von Lymphknotenmetastasen beim Harnblasenkarzinom
    In: Der Urologe, Jg. 52, 2013, Nr. 6, S. 853 – 858
    DOI
  • Jäger, T.; Kramer, J.; Bätz, O.; Rübben, Herbert; Von Ostau, C.; Szarvas, Tibor
    Testosteronmangel - ein unterschätztes Risiko für Männer? : Prävalenz des Hypogonadismus
    In: Der Urologe, Jg. 52, 2013, Nr. 12, S. 1684 – 1689
    DOI
  • Niedworok, Christian; Kretschmer, Inga; Röck, Katharina; vom Dorp, Frank; Szarvas, Tibor; Heß, Jochen A.; Freudenberger, Till; Melchior-Becker, Ariane; Rübben, Herbert; Fischer, Jens W
    The impact of the receptor of hyaluronan-mediated motility (RHAMM) on human urothelial transitional cell cancer of the bladder
    In: PLoS ONE, Jg. 8, 2013, Nr. 9, S. e75681
    DOI (Open Access)
  • Szarvas, Tibor; Jäger, Tobias; Laszlo, Viktoria; Kramer, Gero; Klingler, H. Christoph; vom Dorp, Frank; Romics, Imre; Ergün, Süleyman; Rübben, Herbert
    Circulating angiostatin, bFGF, and Tie2/TEK levels and their prognostic impact in bladder cancer
    In: Urology, Jg. 80, 2012, Nr. 3, S. 737.e13 – 737.e18
    DOI
  • Szarvas, Tibor; vom Dorp, Frank; Niedworok, Christian; Melchior-Becker, Ariane; Fischer, Jens W.; Singer, Bernhard B.; Reis, Henning; Bankfalvi, Agnes; Schmid, Kurt Werner; Romics, Imre; Ergün, Süleyman; Rübben, Herbert
    High insulin-like growth factor mRNA-binding protein 3 (IMP3) protein expression is associated with poor survival in muscle-invasive bladder cancer
    In: BJU International (BJUI), Jg. 110, 2012, Nr. 6B, S. E308 – E317
    DOI (Open Access)
  • Szarvas, Tibor; László, Viktória; vom Dorp, Frank; Reis, Henning; Szendröi, Attila; Romics, Imre; Tilki, Derya; Rübben, Herbert; Ergün, Süleyman
    Serum endostatin levels correlate with enhanced extracellular matrix degradation and poor patients' prognosis in bladder cancer
    In: International Journal of Cancer, Jg. 130, 2012, Nr. 12, S. 2922 – 2929
    DOI
  • Szarvas, Tibor; Kramer, G.; Hess, J.; Tschirdewahn, Stephan; Reis, Henning; Romics, I.; Sevcenco, S.; Totsch, M.; Rübben, Herbert; vom Dorp, Frank
    Tissue MMP-7 expression predicts survival in bladder cancer patients treated with cisplatin-based chemotherapy
    In: The Journal of Urology, Jg. 187, 2012, Nr. Suppl. 4, S. E575 – E575
    DOI
  • vom Dorp, Frank; Pal, Philip; Tschirdewahn, Stephan; Rossi, Roberto; Börgermann, Christof; Schenck, Markus; Becker, Markus; Szarvas, Tibor; Hakenberg, Oliver W.; Rübben, Herbert
    Correlation of pathological and cytological-cytometric grading of transitional cell carcinoma of the urinary tract
    In: Urologia Internationalis, Jg. 86, 2011, Nr. 1, S. 36 – 40
    DOI
  • Szarvas, Tibor; Becker, Markus; vom Dorp, Frank; Meschede, Jan; Scherag, Andre; Bankfalvi, Agnes; Reis, Henning; Schmid, Kurt Werner; Romics, Imre; Rübben, Herbert; Ergün, Süleyman
    Elevated serum matrix metalloproteinase 7 levels predict poor prognosis after radical prostatectomy
    In: International Journal of Cancer, Jg. 128, 2011, Nr. 6, S. 1486 – 1492
    DOI
  • Reis, Henning; Tschirdewahn, Stephan; Szarvas, Tibor; Rübben, Herbert; Schmid, Kurt Werner; Grabellus, Florian
    Expression of GLUT1 is associated with increasing grade of malignancy in non-invasive and invasive urothelial carcinomas of the bladder
    In: Oncology Letters, Jg. 2, 2011, Nr. 6, S. 1149 – 1153
    DOI (Open Access)
  • Szarvas, Tibor; vom Dorp, Frank; Ergün, Süleyman; Rübben, Herbert
    Matrix metalloproteinases and their clinical relevance in urinary bladder cancer
    In: Nature Reviews Urology, Jg. 8, 2011, Nr. 5, S. 241 – 254
    DOI
  • vom Dorp, Frank; Tschirdewahn, Stephan; Olbricht, Tobias; Szarvas, Tibor; Rübben, Herbert
    Photodynamische Diagnostik des Harnblasenkarzinoms
    In: Der Urologe, Jg. 50, 2011, Nr. 9, S. 1068 – 1071
    DOI
  • Szarvas, Tibor; Hoffmann, F.; Becker, M.; Schenck, Marcus; vom Dorp, Frank; Rübben, Herbert; Jäger, T.
    Plasmakonzentrationen von E-Cadherin bei Tumorerkrankungen der Harnblase : Kann die Prognoseabschätzung hiermit verbessert werden?
    In: Der Urologe, Jg. 50, 2011, Nr. 1, S. 64 – 70
    DOI
  • Szarvas, Tibor; Singer, Bernhard B.; Becker, Markus; vom Dorp, Frank; Jäger, Tobias; Szendråi, Attila; Riesz, Péter; Romics, Imre; Rübben, Herbert; Ergün, Süleyman; Szendrői, Attila
    Urinary matrix metalloproteinase-7 level is associated with the presence of metastasis in bladder cancer
    In: BJU International (BJUI), Jg. 107, 2011, Nr. 7, S. 1069 – 1073
    DOI
  • Heß, Jochen A.; Tschirdewahn, Stephan; Szarvas, Tibor; Rossi, R; Rübben, Herbert; vom Dorp, Frank
    Urothelkarzinom der Harnblase : Kombinierte endoskopische und urinzytologische Beurteilung: Lässt es sich sicher einschätzen?
    In: Der Urologe, Jg. 50, 2011, Nr. 6, S. 702 – 705
    DOI
  • Szarvas, Tibor; Jäger, Tobias; Becker, Markus; Tschirdewahn, Stephan; Niedworok, Christian; Kovalszky, Ilona; Rübben, Herbert; Ergün, Süleyman; vom Dorp, Frank
    Validation of Circulating MMP-7 Level as an Independent Prognostic Marker of Poor Survival in Urinary Bladder Cancer
    In: Pathology & Oncology Research, Jg. 17, 2011, Nr. 2, S. 325 – 332
    DOI
  • Szarvas, Tibor; Becker, Markus; vom Dorp, Frank; Gethmann, Carolin; Tötsch, Martin; Bankfalvi, Agnes; Schmid, Kurt Werner; Romics, Imre; Rübben, Herbert; Ergün, Süleyman
    Matrix metalloproteinase-7 as a marker of metastasis and predictor of poor survival in bladder cancer
    In: Cancer Science, Jg. 101, 2010, Nr. 5, S. 1300 – 1308
    DOI (Open Access)
  • Becker, Markus; Szarvas, Tibor; Wittschier, Markus; vom Dorp, Frank; Tötsch, Martin; Schmid, Kurt Werner; Rübben, Herbert; Ergün, Süleyman
    Prognostic impact of plasminogen activator inhibitor type 1 expression in bladder cancer
    In: Cancer, Jg. 116, 2010, Nr. 19, S. 4502 – 4512
    DOI
  • Jäger, Tobias; Becker, Markus; Eisenhardt, Andreas; Tilki, Derya; Tötsch, Martin; Schmid, Kurt Werner; Romics, Imre; Rübben, Herbert; Ergün, Süleyman; Szarvas, Tibor
    The prognostic value of cadherin switch in bladder cancer
    In: Oncology Reports, Jg. 23, 2010, Nr. 4, S. 1125 – 1132
  • Szarvas, Tibor; Jäger, Tobias; Tötsch, Martin; vom Dorp, Frank; Kempkensteffen, Carsten; Kovalszky, Ilona; Romics, Imre; Ergün, Süleyman; Rübben, Herbert
    Angiogenic switch of angiopietins-Tie2 system and its prognostic value in bladder cancer
    In: Clinical Cancer Research, Jg. 14, 2008, Nr. 24, S. 8253 – 8262
    DOI (Open Access)
  • Jäger, Tobias; Szarvas, Tibor; vom Dorp, Frank; Börgermann, Christof; Schenck, Marcus; Schmid, Kurt Werner; Rübben, Herbert
    Einsatz der Siliziumchiptechnologie zur Detektion von Tumormarkern auf Proteinbasis beim Harnblasenkarzinom
    In: Der Urologe, Jg. 46, 2007, Nr. 9, S. 1152 – 1156
    DOI

    • Vorworte / Nachworte

  • Fazekas, Tamás; Szarvas, Tibor; Csizmarik, Anita; Hadaschik, Boris; Nyirády, Péter
    COVID-19 research : promising tracks leading to uro-oncology
    In: International Urology and Nephrology. Berlin: Springer, Jg. 52, 2020, Nr. 6, S. 995 – 997
    DOI (Open Access)

    • Abstracts

  • Florestan J., Koll; Doering, Claudia; Herwig, Leon; Csilla, Olah; Szarvas, Tibor; Koellermann, Jens; Garcia, Cristina Cano; Wenzel, Mike; Hoeh, Benedikt; Banek, Severine; Kluth, Luis; Chun, Felix K. H.; Wild, Peter J.; Reis, Henning
    Molecular Subtypes in Muscle-Invasive Urothelial Bladder Cancer (MIBC) : Comparison of 2 Sequencing Methods - Evaluation of Their Predictive Role in Adjuvant Chemotherapy and Impact of Tumor Microenvironment
    In: The Journal of Molecular Diagnostics. Amsterdam; Bethesda, Md.: Elsevier, Jg. 26, 2024, Nr. Suppl. 6, S. 49 – S50
  • Reis, Henning; Niedworok, Christian; Wiesweg, Marcel; Schuler, Martin; Rübben, Herbert; Hadaschik, Boris; Schmid, Kurt Werner; Szarvas, Tibor
    Potentially Targetable Molecular Alterations in 70 Cases of Urachal Cancer
    Geared to Learn ; USCAP 107th Annual Meeting ; March 17–23, 2018, Vancouver,
    In: Modern Pathology. Amsterdam: Elsevier, Jg. 31, 2018, Nr. Suppl. 2, S. 378
    DOI (Open Access)
  • Niedworok, C.; Szarvas, Tibor; vom Dorp, Frank; Rübben, Herbert; Fischer, J. W.
    Expression of Receptor of Hyaluronan Mediated Motility (RHAMM) is associated with progression of bladder cancer and poor prognosis
    77th Annual Meeting, March 30 – April 1, 2011, Frankfurt a. M., Germany,
    In: Naunyn-Schmiedeberg's Archives of Pharmacology. Berlin: Springer, Jg. 383, 2011, Nr. Suppl. 1, S. 69 – 70
    DOI

    • Beiträge in Sammelwerken und Tagungsbänden

  • Olah, Csilla; Szarvas, Tibor
    A Panel-Based Method for the Reproduction of Distinct Molecular Subtype Classifications of Muscle-Invasive Urothelial Bladder Cancer
    In: Urothelial Carcinoma: Methods and Protocols / Hoffmann, Michèle J.; Gaisa, Nadine T.; Nawroth, Roman; Ecke, Thorsten H. (Hrsg.). Totowa, NJ: NLM (Medline), 2023, S. 27 – 43
    DOI

    • Bücher/Sammelwerke/Tagungsbände

  • Szarvas, Tibor
    Bedeutung molekularer Mechanismen bei der prognostischen Abschätzung urologischer Tumorerkrankungen
    Duisburg, Essen, 2011